Lindbrook Capital, LLC Treace Medical Concepts, Inc. Transaction History
Lindbrook Capital, LLC
- $1.09 Billion
- Q4 2024
A detailed history of Lindbrook Capital, LLC transactions in Treace Medical Concepts, Inc. stock. As of the latest transaction made, Lindbrook Capital, LLC holds 401 shares of TMCI stock, worth $4,110. This represents 0.0% of its overall portfolio holdings.
Number of Shares
401
Previous 250
60.4%
Holding current value
$4,110
Previous $1,000
100.0%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding TMCI
# of Institutions
139Shares Held
39.5MCall Options Held
352KPut Options Held
269K-
Armistice Capital, LLC New York, NY6.2MShares$63.5 Million0.6% of portfolio
-
Black Rock Inc. New York, NY4.07MShares$41.7 Million0.0% of portfolio
-
Morgan Stanley New York, NY3.27MShares$33.6 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.74MShares$28.1 Million0.0% of portfolio
-
William Blair Investment Management, LLC Chicago, IL2.39MShares$24.5 Million0.04% of portfolio
About TREACE MEDICAL CONCEPTS, INC.
- Ticker TMCI
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 55,403,300
- Market Cap $568M
- Description
- Treace Medical Concepts, Inc., an orthopedic medical device company, engages in the design, manufacture, and marketing of medical devices for foot and ankle surgeons in the United States. It offers Lapiplasty procedure that allows podiatric surgeons to treat all three dimensions of the bunion, providing patients with a cosmetic and medical impro...